SCHEMBL24718645

SCHEMBL24718645

O=C(NC1CC(=O)N(Cc2ccccc2C(F)(F)F)C1)c1cc(Br)ccc1O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 1/20 0.45
▸ RIPK1 Q13546 1/20 0.40
▸ P2RX7 Q99572 3/20 0.40
▸ SIRT2 Q8IXJ6 1/20 0.39
▸ SIRT1 Q96EB6 1/20 0.39
▸ TMPRSS4 Q9NRS4 1/20 0.39
▸ HDAC11 Q96DB2 1/20 0.39
▸ MEN1 O00255 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ GAA P10253 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ SIGMAR1 Q99720 1/20 0.37
▸ HSP90AA1 P07900 1/20 0.36
▸ RXFP1 Q9HBX9 1/20 0.36
▸ COMT P21964 1/20 0.36
▸ EPHX2 P34913 1/20 0.36
▸ PPARG P37231 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24718241 0.90 TP53 (0.46) TP53RIPK1P2RX7SIRT2SIRT1
SCHEMBL24718659 0.90 MEN1 (0.46) TP53RIPK1P2RX7SIRT2SIRT1
SCHEMBL24718416 0.90 TP53 (0.46) TP53RIPK1P2RX7SIRT2SIRT1
SCHEMBL24718382 0.90 TP53 (0.46) TP53RIPK1P2RX7SIRT2SIRT1
SCHEMBL24718415 0.89 TP53 (0.49) TP53RIPK1P2RX7SIRT2SIRT1
SCHEMBL24718419 0.89 TP53 (0.45) TP53RIPK1P2RX7TMPRSS4MEN1
SCHEMBL24718840 0.89 TP53 (0.45) TP53RIPK1P2RX7SIRT2SIRT1
SCHEMBL24718637 0.88 TP53 (0.49) TP53RIPK1P2RX7SIRT2SIRT1
SCHEMBL24718834 0.87 TP53 (0.46) TP53RIPK1P2RX7SIRT2SIRT1
SCHEMBL24719134 0.87 NPC1 (0.47) TP53RIPK1P2RX7SIRT2SIRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220363633-A1 SUBSTITUTED PYRROLIDONES AND PIPERIDONES AS SMALL MOLECULE INHIBITORS OF EZH2 AND EED PROTEIN BINDING UNITED STATES GOVERNMENT 2022-11-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220363633-A1 SUBSTITUTED PYRROLIDONES AND PIPERIDONES AS SMALL MOLECULE INHIBITORS OF EZH2 AND EED PROTEIN BINDING EED, EZH2, ELP1 TP53 284/4885RIPK1 1371/4885P2RX7 4354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback